DelMar Pharmaceuticals to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 10-12, 2017


DelMar Pharmaceuticals LogoVANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 6, 2017 /PRNewswire/ — DelMar Pharmaceuticals (Nasdaq: DMPI) (“DelMar” and “the Company”), a biopharmaceutical company focused on the development of new cancer therapies, today announced that Jeffrey Bacha, president & CEO of…–renshaw-global-investment-conference-on-september-10-12-2017-300514953.html